Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Wex, Jaro"'
Autor:
Wex, Jaro1 (AUTHOR) jaro.wex@recordati.com, Szkultecka-Debek, Monika2 (AUTHOR), Drozd, Mariola3 (AUTHOR), King, Sarah4 (AUTHOR), Zibelnik, Natasa5 (AUTHOR)
Publikováno v:
Orphanet Journal of Rare Diseases. 7/20/2023, Vol. 18 Issue 1, p1-14. 14p.
Autor:
Cockle, Sarah M., Stynes, Gillian, Gunsoy, Necdet B., Parks, Daniel, Alfonso-Cristancho, Rafael, Wex, Jaro, Bradford, Eric S., Albers, Frank C., Willson, Jenny
Publikováno v:
In Respiratory Medicine February 2017 123:140-148
Additional file 2: Appendix 2. Example rating assessment template.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81180db24268271654c77be3fe95be7f
Additional file 3: Appendix 3. Data extraction tables.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ce57ffa6fb9ef4b7a2344085c83c945
Additional file 1: Appendix 1. Search strategies.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aacd40bccd03f0913cece72416118a6
Additional file 4: Appendix 4. Narrative summaries of the evidence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79cb13545478e5e5e8d38cf0df86fa62
Publikováno v:
In European Journal of Obstetrics and Gynecology August 2011 157(2):128-135
Publikováno v:
BMC Pregnancy and Childbirth, Vol 9, Iss 1, p 23 (2009)
Abstract Background The use of tocolytics is central in delaying birth; however, therapeutic options vary in effectiveness and adverse events profiles, which in turn could have consequences for medical resource use and cost of treatment. Betamimetics
Externí odkaz:
https://doaj.org/article/9ade690604e24fe2ba5d98dea19a6a2c
Autor:
Svedsater, Henrik, Stynes, Gillian, Wex, Jaro, Frith, Lucy, Leather, David, Castelnuovo, Emanuela, Detry, Michelle, Berry, Scott
Table S1: Summary of studies and treatment arms included in the updated primary mixed treatment comparison analysis. Table S2: Posterior probability of non-inferiority for FF/VI versus other relevant ICS/LABA combination therapies Table S3: Posterior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13be493af7173faf44a308f08778c49b
Autor:
Svedsater, Henrik, Stynes, Gillian, Wex, Jaro, Frith, Lucy, Leather, David, Castelnuovo, Emanuela, Detry, Michelle, Berry, Scott
e-table 1: Characteristics of the studies and treatment arms included in the MTC. e-table 2: Results of mixed treatment comparisons for ICS/LABA treatments of interest (full covariate model, if available). e-table 3: Summary of findings of covariate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be49cbc6879ff0b04fb1ee9844c3fe1